Glennon, RA; Gessner, PK. Serotonin receptor binding affinities of tryptamine analogues. J. Med. Chem., 1 Jan 1979, 22 (4), pp 428–432. 731 kB. https://doi.org/10.1021/jm00190a014
Gornez-Jeria, JS; Morales-Lagos, D; Cassels, BK; Saavedra-Aguilar, JC. Electronic structure and serotonin receptor binding affinity of 7-substituted tryptamines QSAR of 7-substituted tryptamines. Quant. Struct.-Act. Relat., 1 Jan 1986, 5 (4), 153–157. 577 kB. https://doi.org/10.1002/qsar.19860050404
Glennon, RA; Lee, M; Rangisetty, JB; Dukat, M; Roth, BL; Savage, JE; McBridge, A; Rauser, L; Hufeisen, SJ; Lee, DKH. 2-Substituted tryptamines: Agents with selectivity for 5-HT6 serotonin receptors. J. Med. Chem., 9 Mar 2000, 43 (5), 1011–1018. 137 kB. https://doi.org/10.1021/jm990550b #6 NMR
Chapman, SJ. PeakAL: Protons I Have Known and Loved, Too — Another Fifty Shades of Grey-Market Spectra. BLOTTER, 1 Mar 2018, 3 (1). 1.2 MB. https://doi.org/10.16889/isomerdesign-5
Chapman, SJ. PeakAL: Protons I Have Known and Loved, Too — Another Fifty Shades of Grey-Market Spectra. Supplementary Data. BLOTTER, 1 Mar 2018, 3 (1). 5.7 MB. https://doi.org/10.16889/isomerdesign-5-supp
EMCDDA. New drugs in Europe, 2013, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 Jul 2014. 311 kB.
Zhang, S; Fan, Y; Shi, Z; Cheng, S. DFT-based QSAR and action mechanism of phenylalkylamine and tryptamine hallucinogens. Chin. J. Chem., 1 Apr 2011, 29 (4), 623–630. 166 kB. https://doi.org/10.1002/cjoc.201190132 #61
Shulgin, AT. Basic Pharmacology and Effects. In Hallucinogens. A Forensic Drug Handbook; Laing, R; Siegel, JA, Eds., Academic Press, London, 24 Apr 2003; pp 67–137. 6.3 MB.
Barlow, RB; Khan, I. Actions of some analogues of tryptamine on the isolated rat uterus and on the isolated rat fundus strip preparations. Br. J. Pharmacol., 1 Mar 1959, 14 (1), 99–107. 1.9 MB. https://doi.org/10.1111/j.1476-5381.1959.tb00934.x #12 other
Åstrand, A; Guerrieri, D; Vikingsson, S; Kronstrand, R; Green, H. In vitro characterization of new psychoactive substances at the μ-opioid, CB1, 5HT1A, and 5-HT2A receptors—On-target receptor potency and efficacy, and off-target effects. Forensic Sci. Int., 1 Dec 2020, 317, 110553. 1.7 MB. https://doi.org/10.1016/j.forsciint.2020.110553 #2-Me-DMT
N-Isopropyltryptamine · IPT · N-iP-T · NIPT
1-Methyl-N,N-dimethyltryptamine · 1-Methyl-DMT · 1-TMT
ATMT · α-Methyl-N,N-dimethyltryptamine · α-Methyl-DMT · α-TMT
α-Methyl-N-ethyltryptamine · α-Methyl-NET
α-PT · α-Propyltryptamine
N-Methyl-N-ethyltryptamine · MET
5,N,N-TMT · 5-Methyl-N,N-dimethyltryptamine · 5-Methyl-DMT
6-Methyl-N,N-dimethyltryptamine · 6-Methyl-DMT · N,N,6-TMT
7,N,N-TMT · 7-Methyl-N,N-Dimethyltryptamine · 7-Methyl-DMT
4-Methyl-AET · 4-Methyl-α-ethyltryptamine
7-Methyl-AET · 7-Methyl-α-ethyltryptamine
7-Methyl-N,N-diimethyl-isotryptamine · 7-Methyl-iso-DMT
6-Methyl-N,N-diimethyl-isotryptamine · 6-Methyl-iso-DMT
5-Methyl-N,N-diimethyl-isotryptamine · 5-Methyl-iso-DMT
4-Methyl-N,N-dimethyl-isotryptamine · 4-Methyl-iso-DMT
5-Methyl-AET · 5-Methyl-α-ethyltryptamine
Homo-isotryptamine · homo-iso-DMT
2-Methyl-N,N-dimethyl-isotryptamine · 2-Methyl-iso-DMT
5-Isopropyl-T · 5-Isopropyltryptamine
4-Methyl-N,N-dimethyltryptamine · 4-Methyl-DMT